• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶 7(Matrilysin/MMP-7)切割与神经信号蛋白 3A(Semaphorin 3A)结合的硫酸乙酰肝素蛋白聚糖 2(HSPG2)/Perlecan 复合物,促进前列腺癌细胞中黏着斑激酶(FAK)介导的基质浸润。

Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.

机构信息

Department of BioSciences, Rice University, Houston, TX, 77005, USA.

Department of Diagnostic and Biomedical Sciences, University of Texas Health Science Center at Houston, School of Dentistry, Houston, TX, 77054, USA.

出版信息

Sci Rep. 2018 May 8;8(1):7262. doi: 10.1038/s41598-018-25435-3.

DOI:10.1038/s41598-018-25435-3
PMID:29740048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5940808/
Abstract

Interrupting the interplay between cancer cells and extracellular matrix (ECM) is a strategy to halt tumor progression and stromal invasion. Perlecan/heparan sulfate proteoglycan 2 (HSPG2) is an extracellular proteoglycan that orchestrates tumor angiogenesis, proliferation, differentiation and invasion. Metastatic prostate cancer (PCa) cells degrade perlecan-rich tissue borders to reach bone, including the basement membrane, vasculature, reactive stromal matrix and bone marrow. Domain IV-3, perlecan's last 7 immunoglobulin repeats, mimics native proteoglycan by promoting tumoroid formation. This is reversed by matrilysin/matrix metalloproteinase-7 (MMP-7) cleavage to favor cell dispersion and tumoroid dyscohesion. Both perlecan and Domain IV-3 induced a strong focal adhesion kinase (FAK) dephosphorylation/deactivation. MMP-7 cleavage of perlecan reversed this, with FAK in dispersed tumoroids becoming phosphorylated/activated with metastatic phenotype. We demonstrated Domain IV-3 interacts with the axon guidance protein semaphorin 3A (Sema3A) on PCa cells to deactivate pro-metastatic FAK. Sema3A antibody mimicked the Domain IV-3 clustering activity. Direct binding experiments showed Domain IV-3 binds Sema3A. Knockdown of Sema3A prevented Domain IV-3-induced tumoroid formation and Sema3A was sensitive to MMP-7 proteolysis. The perlecan-Sema3A complex abrogates FAK activity and stabilizes PCa cell interactions. MMP-7 expressing cells destroy the complex to initiate metastasis, destroy perlecan-rich borders, and favor invasion and progression to lethal bone disease.

摘要

中断癌细胞与细胞外基质(ECM)的相互作用是阻止肿瘤进展和基质浸润的一种策略。多配体蛋白聚糖 2(HSPG2)是一种细胞外蛋白聚糖,可协调肿瘤血管生成、增殖、分化和侵袭。转移性前列腺癌(PCa)细胞降解富含硫酸乙酰肝素蛋白聚糖的组织边界以到达骨骼,包括基底膜、脉管系统、反应性基质和骨髓。多配体蛋白聚糖的最后 7 个免疫球蛋白重复序列 IV-3 模拟天然蛋白聚糖,通过促进肿瘤球形成来促进肿瘤发生。基质金属蛋白酶-7(MMP-7)的切割将其逆转,有利于细胞分散和肿瘤球解聚。多配体蛋白聚糖和 IV-3 结构域都诱导强烈的粘着斑激酶(FAK)去磷酸化/失活。多配体蛋白聚糖的 MMP-7 切割逆转了这一点,分散的肿瘤球中的 FAK 发生磷酸化/激活,具有转移表型。我们证明 IV-3 结构域与 PCa 细胞上的轴突导向蛋白神经纤毛蛋白 3A(Sema3A)相互作用,使促转移的 FAK 失活。Sema3A 抗体模拟了 IV-3 结构域的聚集活性。直接结合实验表明 IV-3 结构域结合 Sema3A。Sema3A 的敲低阻止了 IV-3 结构域诱导的肿瘤球形成,Sema3A 对 MMP-7 蛋白水解敏感。多配体蛋白聚糖-Sema3A 复合物使 FAK 失活并稳定 PCa 细胞相互作用。表达 MMP-7 的细胞破坏复合物以启动转移,破坏富含多配体蛋白聚糖的边界,并有利于侵袭和进展为致命的骨疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/28f1c53c607b/41598_2018_25435_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/023e9f6f3e5e/41598_2018_25435_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/478fd530b487/41598_2018_25435_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/c8f1313ebed6/41598_2018_25435_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/4c2dc02406fe/41598_2018_25435_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/05d399a5bd31/41598_2018_25435_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/fdf25e2d25b1/41598_2018_25435_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/9e8781ee6b29/41598_2018_25435_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/28f1c53c607b/41598_2018_25435_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/023e9f6f3e5e/41598_2018_25435_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/478fd530b487/41598_2018_25435_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/c8f1313ebed6/41598_2018_25435_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/4c2dc02406fe/41598_2018_25435_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/05d399a5bd31/41598_2018_25435_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/fdf25e2d25b1/41598_2018_25435_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/9e8781ee6b29/41598_2018_25435_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef2f/5940808/28f1c53c607b/41598_2018_25435_Fig8_HTML.jpg

相似文献

1
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.基质金属蛋白酶 7(Matrilysin/MMP-7)切割与神经信号蛋白 3A(Semaphorin 3A)结合的硫酸乙酰肝素蛋白聚糖 2(HSPG2)/Perlecan 复合物,促进前列腺癌细胞中黏着斑激酶(FAK)介导的基质浸润。
Sci Rep. 2018 May 8;8(1):7262. doi: 10.1038/s41598-018-25435-3.
2
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.基质溶素/基质金属蛋白酶-7(MMP7)对基底膜聚糖/HSPG2的切割产生了一个分子开关,以改变前列腺癌细胞的行为。
Matrix Biol. 2014 Jun;36:64-76. doi: 10.1016/j.matbio.2014.04.005. Epub 2014 May 14.
3
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.基质金属蛋白酶7/基质溶素对基底膜聚糖-信号素3A-丛蛋白A1-神经纤毛蛋白-1(PSPN)复合物的切割引发前列腺癌细胞黏附丧失和迁移。
Int J Mol Sci. 2021 Mar 22;22(6):3218. doi: 10.3390/ijms22063218.
4
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.硫酸乙酰肝素蛋白聚糖/基底膜聚糖(Perlecan/HSPG2)和基质溶素/基质金属蛋白酶-7(matrilysin/MMP-7)作为组织侵袭指标:288例前列腺癌根治术患者队列中的组织定位及循环硫酸乙酰肝素蛋白聚糖片段
Oncotarget. 2016 Mar 1;7(9):10433-47. doi: 10.18632/oncotarget.7197.
5
Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.NFκB 的转录激活增加了硬皮前列腺肿瘤微环境中 perlecan/HSPG2 的表达。
J Cell Biochem. 2014 Jul;115(7):1322-33. doi: 10.1002/jcb.24788.
6
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.边界巡逻:对基底膜聚糖/硫酸乙酰肝素蛋白聚糖2在细胞和组织边界独特作用的见解
Matrix Biol. 2014 Feb;34:64-79. doi: 10.1016/j.matbio.2013.08.004. Epub 2013 Aug 31.
7
Engineered small extracellular vesicles for targeted delivery of perlecan to stabilise the blood-spinal cord barrier after spinal cord injury.工程化小细胞外囊泡用于靶向递送基底膜聚糖以稳定脊髓损伤后的血脊髓屏障。
Clin Transl Med. 2025 Jun;15(6):e70381. doi: 10.1002/ctm2.70381.
8
Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.紫草素通过靶向磷酸化β-连环蛋白和磷酸化PI3K/Akt抑制人胶质母细胞瘤细胞的迁移和侵袭:一种传统中药抗胶质瘤疗效的潜在机制。
Int J Mol Sci. 2015 Oct 9;16(10):23823-48. doi: 10.3390/ijms161023823.
9
Semaphorin 3A protects against thoracic aortic aneurysm dissection by suppressing aortic angiogenesis.信号素3A通过抑制主动脉血管生成来预防胸主动脉瘤夹层形成。
Angiogenesis. 2025 Jun 28;28(3):39. doi: 10.1007/s10456-025-09992-6.
10
A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.核心蛋白聚糖结构域IV中的一种新型肽序列可支持细胞黏附、铺展和黏着斑激酶激活。
Matrix Biol. 2008 Mar;27(2):150-60. doi: 10.1016/j.matbio.2007.09.007. Epub 2007 Oct 10.

引用本文的文献

1
Ageing-Related Changes in Ultrastructural Bone Matrix Composition and Osteocyte Mechanosensitivity.衰老相关的超微结构骨基质组成变化和骨细胞机械敏感性
Curr Osteoporos Rep. 2025 Aug 12;23(1):35. doi: 10.1007/s11914-025-00927-0.
2
A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer.一种用于预测前列腺癌预后、抗雄激素耐药性和药物选择的新型骨转移相关基因特征。
J Bone Oncol. 2025 Mar 20;52:100673. doi: 10.1016/j.jbo.2025.100673. eCollection 2025 Jun.
3
Distinct role of perlecan in mesenchymal tissue regeneration via genetic and epigenetic modification.

本文引用的文献

1
Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling.Gli1通过激活上皮-间质转化(EMT)和PI3K-AKT信号通路,以Foxm1依赖的方式促进结直肠癌转移。
Oncotarget. 2016 Dec 27;7(52):86134-86147. doi: 10.18632/oncotarget.13348.
2
Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration.从含核心蛋白聚糖结构域I功能化的电纺聚(ε-己内酯)支架持续递送重组人骨形态发生蛋白-2用于骨再生
J Exp Orthop. 2016 Dec;3(1):25. doi: 10.1186/s40634-016-0057-1. Epub 2016 Oct 6.
3
通过基因和表观遗传修饰,基底膜聚糖在间充质组织再生中的独特作用。
Chem Eng J. 2025 Mar 15;508. doi: 10.1016/j.cej.2025.161103. Epub 2025 Feb 27.
4
Comprehensive pan-cancer analysis of HSPG2 as a marker for prognosis.作为预后标志物的HSPG2的全面泛癌分析。
BMC Med Genomics. 2025 Feb 17;18(1):33. doi: 10.1186/s12920-025-02103-w.
5
Diverse and multifunctional roles for perlecan () in repair of the intervertebral disc.基底膜聚糖()在椎间盘修复中的多样且多功能作用。
JOR Spine. 2024 Jul 29;7(3):e1362. doi: 10.1002/jsp2.1362. eCollection 2024 Sep.
6
Extracellular cancer‑associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor‑promoting roles and prognosis biomarker functions.细胞外癌相关成纤维细胞:宫颈癌微环境中的一个新亚群,具有促肿瘤作用和预后生物标志物功能。
Oncol Lett. 2024 Feb 22;27(4):167. doi: 10.3892/ol.2024.14300. eCollection 2024 Apr.
7
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.甲状腺间变性癌的基因组和进化景观。
Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26.
8
The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.细胞外基质和整合素黏附复合体相关分子在前列腺癌生物标志物发现中的潜力
Biomedicines. 2023 Dec 28;12(1):79. doi: 10.3390/biomedicines12010079.
9
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.前列腺肿瘤微环境的景观和相关治疗靶点的研究进展。
Acta Biochim Biophys Sin (Shanghai). 2023 Jun 9;55(6):956-973. doi: 10.3724/abbs.2023092.
10
Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion.肿瘤微环境中的重要细胞和因子参与神经周围浸润。
Cancers (Basel). 2023 Feb 21;15(5):1360. doi: 10.3390/cancers15051360.
Basement membrane fragments in the context of the epithelial-to-mesenchymal transition.
基底层膜片段在上皮-间充质转化中的作用。
Eur J Cell Biol. 2016 Nov;95(11):427-440. doi: 10.1016/j.ejcb.2016.06.002. Epub 2016 Jun 18.
4
MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.基质金属蛋白酶7(MMP7)在细胞核中与ARF相互作用,以增强体内前列腺癌进展的肿瘤微环境。
Oncotarget. 2016 Jul 26;7(30):47609-47619. doi: 10.18632/oncotarget.10251.
5
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.肿瘤坏死因子-α和干扰素-γ通过核因子κB刺激乳腺癌、子宫内膜癌和卵巢癌中的MUC16(癌抗原125)表达。
Oncotarget. 2016 Mar 22;7(12):14871-84. doi: 10.18632/oncotarget.7652.
6
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.硫酸乙酰肝素蛋白聚糖/基底膜聚糖(Perlecan/HSPG2)和基质溶素/基质金属蛋白酶-7(matrilysin/MMP-7)作为组织侵袭指标:288例前列腺癌根治术患者队列中的组织定位及循环硫酸乙酰肝素蛋白聚糖片段
Oncotarget. 2016 Mar 1;7(9):10433-47. doi: 10.18632/oncotarget.7197.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
Structural basis for PECAM-1 homophilic binding.血小板内皮细胞黏附分子-1(PECAM-1)嗜同性结合的结构基础。
Blood. 2016 Feb 25;127(8):1052-61. doi: 10.1182/blood-2015-07-660092. Epub 2015 Dec 23.
9
Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix.核心蛋白聚糖/HSPG2的单分子力测量:骨细胞周细胞基质的关键成分
Matrix Biol. 2016 Mar;50:27-38. doi: 10.1016/j.matbio.2015.11.001. Epub 2015 Nov 4.
10
Induction of forkhead box M1 (FoxM1) by EGF through ERK signaling pathway promotes trophoblast cell invasion.表皮生长因子(EGF)通过细胞外信号调节激酶(ERK)信号通路诱导叉头框蛋白M1(FoxM1),从而促进滋养层细胞侵袭。
Cell Tissue Res. 2015 Nov;362(2):421-30. doi: 10.1007/s00441-015-2211-y. Epub 2015 May 30.